Beaphar One Dose Wormer for Small Dogs and Puppies, 100 mg Film Coated Tablets

Nazione: Regno Unito

Lingua: inglese

Fonte: VMD (Veterinary Medicines Directorate)

Principio attivo:

Nitroscanate

Commercializzato da:

Elanco Europe Ltd

Codice ATC:

QP52AX01

INN (Nome Internazionale):

Nitroscanate

Forma farmaceutica:

Film-coated tablet

Tipo di ricetta:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Gruppo terapeutico:

Dogs

Area terapeutica:

Anthelmintic

Stato dell'autorizzazione:

Expired

Data dell'autorizzazione:

2000-06-30

Scheda tecnica

Revised: November 2018
AN: 00829/2018
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Beaphar One Dose Wormer for Small Dogs and Puppies, 100 mg film-coated
tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient
mg/tablet
Nitroscanate
100
For a full list of excipients see section 6.1.
3.
PHARMACEUTICAL FORM
Film coated tablet.
Yellowish-white to light beige round, film coated tablet, with
‘kx’ imprinted on one
side and ‘CGV’ on the other.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
A broad spectrum anthelmintic for use in small dogs and puppies up to
6 kg. It is
highly effective in a single dose against common canine nematodes and
cestodes
in the UK: _Toxocara canis, Toxascaris leonina, Ancylostoma caninum,
Uncinaria _
_stenocephala, Taenia ovis, Taenia hydatigena, Taenia pisiformis _and
_Dipylidium _
_caninum._
At the recommended dosage, the product gives limited control of
_Echinococcus _
_granulosus._
4.3
CONTRAINDICATIONS
Do not administer if your dog is sick or recovering from an illness.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: November 2018
AN: 00829/2018
Page 2 of 4
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Do not repeat treatment if vomiting occurs shortly after dosing.
ii.
Special precautions to be taken by the person administering the
medicinal
product to animals
Tablets are film coated and should not be broken or divided.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
The tablets, when administered as recommended are unlikely to cause
vomiting.
Do not repeat treatment if vomiting occurs shortly after dosing.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not contraindicated in pregnant animals. Nursing females should be
treated at the
same time and as frequently as puppies up to 12 weeks of age (i.e. 2,
4, 6, 8,
12 weeks).
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9
AMOUNT(S) TO B